Dashboard
Manage Tickers

ENOVEnovis CORP

NYSE enovis.com


$ 52.50 $ 0.21 (0.4 %)    

Friday, 17-May-2024 15:59:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 52.41
$ 51.83
$ 0.00 x 0
$ 0.00 x 0
$ 51.69 - $ 52.54
$ 43.04 - $ 66.14
335,639
na
2.87B
$ 1.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-29-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-07-2023 09-29-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-04-2022 07-01-2022 10-Q
9 05-10-2022 04-01-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 11-04-2021 10-01-2021 10-Q
12 07-28-2021 07-02-2021 10-Q
13 04-29-2021 04-02-2021 10-Q
14 02-18-2021 12-31-2020 10-K
15 10-29-2020 10-02-2020 10-Q
16 08-06-2020 07-03-2020 10-Q
17 05-07-2020 04-03-2020 10-Q
18 02-24-2020 12-31-2019 10-K
19 10-31-2019 09-27-2019 10-Q
20 08-06-2019 06-28-2019 10-Q
21 05-08-2019 03-29-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 10-25-2018 09-28-2018 10-Q
24 08-06-2018 06-29-2018 10-Q
25 05-03-2018 03-30-2018 10-Q
26 02-16-2018 12-31-2017 10-K
27 11-06-2017 09-29-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 02-14-2017 12-31-2016 10-K
31 10-27-2016 09-30-2016 10-Q
32 07-28-2016 07-01-2016 10-Q
33 05-03-2016 04-01-2016 10-Q
34 02-16-2016 12-31-2015 10-K
35 10-22-2015 09-25-2015 10-Q
36 07-23-2015 06-26-2015 10-Q
37 04-23-2015 03-27-2015 10-Q
38 02-17-2015 12-31-2014 10-K
39 10-23-2014 09-26-2014 10-Q
40 07-25-2014 06-27-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

top-4-health-care-stocks-which-could-rescue-your-portfolio-this-month
Top 4 Health Care Stocks Which Could Rescu...
05/07/2024 11:18:46

a-closer-look-at-6-analyst-recommendations-for-enovis
A Closer Look at 6 Analyst Recommendations...
05/03/2024 12:00:38

needham-reiterates-buy-on-enovis-maintains-82-price-target
Needham Reiterates Buy on Enovis, Maintain...
05/03/2024 09:45:52

Needham analyst Mike Matson reiterates Enovis (NYSE:ENOV) with a Buy and maintains $82 price target.

enovis-expects-2024-adjusted-ebitda-of-368m-383m-compared-with-the-previous-outlook-of-365m-380m
Enovis Expects 2024 Adjusted EBITDA Of $36...
05/02/2024 10:13:53

enovis-expects-2024-adjusted-eps-of-252-267-versus-prior-guidance-of-250-265-and-consensus-of-260
Enovis Expects 2024 Adjusted EPS Of $2.52-...
05/02/2024 10:13:31

enovis-expects-2024-revenue-of-approximate-206b-216b-versus-prior-expectations-of-205b-215b-and-consensus-of-212b
Enovis Expects 2024 Revenue Of Approximate...
05/02/2024 10:11:41

enovis-q1-2024-adj-eps-050-beats-048-estimate-sales-516266m-beat-503895m-estimate
Enovis Q1 2024 Adj EPS $0.50 Beats $0.48 E...
05/02/2024 10:03:53

Enovis (NYSE:ENOV) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.48 by 4.17 pe...

Core News & Articles
Banzai Welcomes Over 580 New Customers In ...
04/16/2024 12:04:58

Banzai International, Inc. (NASDAQ:BNZI), a leading marketing technology company providing essential marketing and sales soluti...

needham-reiterates-buy-on-enovis-maintains-82-price-target
Needham Reiterates Buy on Enovis, Maintain...
04/10/2024 12:18:01

Needham analyst Mike Matson reiterates Enovis (NYSE:ENOV) with a Buy and maintains $82 price target.

canaccord-genuity-maintains-buy-on-enovis-raises-price-target-to-75
Canaccord Genuity Maintains Buy on Enovis,...
02/23/2024 14:39:35

Canaccord Genuity analyst Caitlin Cronin maintains Enovis (NYSE:ENOV) with a Buy and raises the price target from $73 to $75.

needham-maintains-buy-on-enovis-raises-price-target-to-82
Needham Maintains Buy on Enovis, Raises Pr...
02/23/2024 10:00:23

Needham analyst Mike Matson maintains Enovis (NYSE:ENOV) with a Buy and raises the price target from $73 to $82.

medtech-firm-enovis-sets-strong-2024-targets-as-q4-earnings-beat-expectations-analyst-says-growth-intact
Medtech Firm Enovis Sets Strong 2024 Targe...
02/22/2024 18:50:58

Enovis reports Q4 results with net sales surging 11% YoY, reaching $455 million. The growth is attributed to strong performance...

enovis-forecasts-fiscal-year-2024-adjusted-eps-of-250-265-versus-consensus-of-271
Enovis Forecasts Fiscal Year 2024 Adjusted...
02/22/2024 11:04:54

enovis-forecasts-fiscal-year-2024-revenues-of-205b-215b-versus-consensus-of-212b
Enovis Forecasts Fiscal Year 2024 Revenues...
02/22/2024 11:03:55

enovis-q4-adjusted-eps-079-beats-074-estimate-sales-45502m-beat-44536m-estimate
Enovis Q4 Adjusted EPS $0.79 Beats $0.74 E...
02/22/2024 11:01:22

Enovis (NYSE:ENOV) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.74 by 6.76 pe...

earnings-scheduled-for-february-22-2024
Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

earnings-outlook-for-enovis
Earnings Outlook For Enovis
02/21/2024 15:01:30

5-analysts-have-this-to-say-about-enovis
5 Analysts Have This To Say About Enovis
02/13/2024 12:01:06

stephens--co-initiates-coverage-on-enovis-with-overweight-rating-announces-price-target-of-72
Stephens & Co. Initiates Coverage On Enovi...
02/13/2024 11:09:10

Stephens & Co. analyst George Sellers initiates coverage on Enovis (NYSE:ENOV) with a Overweight rating and announces Pr...

ubs-initiates-coverage-on-enovis-with-buy-rating-announces-price-target-of-75
UBS Initiates Coverage On Enovis with Buy ...
01/22/2024 11:00:11

UBS analyst Danielle Antalffy initiates coverage on Enovis (NYSE:ENOV) with a Buy rating and announces Price Target of $75.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION